The Heron Therapeutics Inc. (HRTX) Stock Rating Reaffirm by the JMP Securities

Posted under Uncategorized on December 10th, 2016 by

The biotechnology company reported ($1.24) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($1.17) …

Leave a Comment